CV7 COST-EFFECTIVENESS OF A NEW ANTITHROMBOTIC AGENT- A COMPARISON ACROSS COUNTRIES OF THROMBOPROPHYLAXIS WITH FONDAPARINUX FOLLOWING MAJOR ORTHOPAEDIC SURGERY
Abstract
Authors
MC Minjoulat-Rey P Carita L Annemans X Badia PM Bossuyt J Posnett S Gabriel